<unk>  is a Alkylating Drug that is FDA approved for the treatment of Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma (NHL).   Common adverse reactions include injection site pain, pruritus, rash, weight loss, constipation, diarrhea, loss of appetite, nausea, stomatitis, vomiting, headache, cough, dyspnea, dehydration, fatigue , fever.
Bendamustine
Fotemustine
Estramustine
Lomustine
Carmustine 
Prednimustine
Idoxuridine
Ifosfamide